City

Bethesda (1)

Condition

CML (Chronic Myelogenous Leukemia (2)

Acute Lymphoblastic Leukemia (1)

CLL (Chronic Lymphocytic Leukemia) (1)

Chronic Myelogenous Leukemia (1)

Myelodysplastic Syndrome (MDS) (1)

Overall Status

Completed (1)

Not yet recruiting (1)

Sign in for free

Phase

phase 1 (1)

phase 1/phase 2 (1)

Sponsor

Lindsay Rein, MD (1)

National Heart, Lung, and Blood Institute (NHLBI) (1)

Collaborator

Kiadis Pharma (1)

Intervention

kds-1001 (1)

stem cell transplantation (1)

Study Documents

Intervention Type

drug (1)

procedure (1)

Funder Type

NIH (1)

Other (1)

Study Type

Interventional (2)

CML (Chronic Myelogenous Leukemia

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

CML (Chronic Myelogenous Leukemia Trial (KDS-1001)

Not yet recruiting

CML (Chronic Myelogenous Leukemia

KDS-1001

(no location specified)

Jul 27, 2022

Myelodysplastic Syndrome (MDS), Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial run by the NHLBI (Stem Cell

Completed

Myelodysplastic Syndrome (MDS)
+4 more

Stem Cell Transplantation

Bethesda, Maryland

National Institutes of Health Clinical Center, 9000 Rockville Pi

Jul 3, 2018